Vaccines and fingolimod

A study of 136 people with MS found that those on fingolimod (Gilenya) were less likely to see the benefits of vaccinations against flu or tetanus, though around two in five people on the drug were protected. MS Research Australia Vaccination and immunisation - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news